This week, hosts Heather and Matthew are joined by Mark Wainner, President of the Ambulatory Surgery Center Association (ASCA), to explore how ambulatory surgery centers (ASCs) are transforming the health care landscape. With over 6,400 Medicare-certified ASCs nationwide, these facilities are delivering high-quality, cost-effective care while saving Medicare billions. Mark shares insights on the latest regulatory changes, quality reporting, and overall industry growth. We also dive into the challenges ahead, including anesthesia shortages and physician employment trends. Tune in for a look at the future of outpatient surgical care!

This week on Taking The Pulse, Heather and Seth record at the NCLifeSci 2025 Annual Meeting with Bobby Patrick, Senior Vice President of Government Affairs at AdvaMed. Bobby shares how the world’s largest medical technology association is advocating for expanded Medicare coverage of breakthrough devices, navigating the evolving role of AI in diagnostics, and addressing supply chain and tariff challenges. We also explore how AI is enhancing physician decision-making and how patient trust and data security remain central to innovation. Tune in now for a timely look at the policy and technology shaping the future of medtech!

This week on Taking The Pulse, Heather and Matthew are joined by one of the nation's leading voices in public health: Dr. Georges Benjamin, Executive Director of the American Public Health Association (APHA). With over two decades of leadership at the APHA, Dr. Benjamin shares how the organization is advocating for Medicaid access, preparing for future health emergencies, and working to rebuild public trust in the wake of COVID-19. We dive into the impact of the “Big Beautiful Bill,” the challenges of vaccine skepticism, and how the APHA is mobilizing thousands of public health professionals to make public health a top national priority. Tune in now!

This week on the podcast, Heather and Matthew are joined by Gil Roth, President of the Pharma & Biopharma Outsourcing Association (PBOA), which represents the regulatory, legislative, and general business interests of Contract Development and Manufacturing Organizations (CDMOs) in the bio/pharma space. Gil shares how CDMOs are navigating regulatory uncertainty, the potential impact of tariffs on drug pricing and supply chains, and what recent executive orders could mean for innovation and access to care. Tune in now!